Arbutus Biopharma Corporation Banner Image

Arbutus Biopharma Corporation has reached its limit for free report views

Work for Arbutus Biopharma Corporation? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Arbutus Biopharma Corporation

Ticker ABUS

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Warminster, Pennsylvania

Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering,developing and commercializing a cure for people with chronic hepatitis B virus ("HBV") infection. They are advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery…More

Visit website

REPORT RATINGS

4.8 / 5.0 (206)

Arbutus Biopharma Corporation reports have an aggregate usefulness score of 4.8 based on 206 reviews.

Arbutus Biopharma Corporation